Trivalent hemagglutinin nanoparticle influenza vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trivalent hemagglutinin nanoparticle influenza vaccine, covering 2025-03-11 to 2025-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine [Phase 2, Phase 3]